Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild‐type proteins

  • Kazutomo Toyofuku
    Laboratory of Cell BiologyNational Cancer InstituteNational Institutes of HealthBethesdaMaryland20892USA
  • Ikuo Wada
    Department of BiochemistrySapporo Medical UniversitySapporoJapan
  • Julio C. Valencia
    Pathology SectionNational HeartLung and Blood InstituteNational Institutes of HealthBethesdaMaryland20892USA
  • Tsuneto Kushimoto
    Laboratory of Cell BiologyNational Cancer InstituteNational Institutes of HealthBethesdaMaryland20892USA
  • Victor J. Ferrans
    Pathology SectionNational HeartLung and Blood InstituteNational Institutes of HealthBethesdaMaryland20892USA
  • Vincent J. Hearing
    Laboratory of Cell BiologyNational Cancer InstituteNational Institutes of HealthBethesdaMaryland20892USA

収録刊行物

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ